NASDAQ: CEROCero Therapeutics Holdings Inc Stock Ownership - Who owns Cero Therapeutics Holdings?
Insider buying vs selling
Have Cero Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-13 | 2,998,908 | $0.06 | $179.93kSell |
| Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-12 | 1,614,541 | $0.07 | $113.02kSell |
| Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-11 | 1,343,801 | $0.08 | $107.50kSell |
| Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-10 | 1,570,947 | $0.09 | $141.39kSell |
| Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-09 | 850,543 | $0.11 | $93.56kSell |
| Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-06 | 1,236,874 | $0.12 | $148.42kSell |
CERO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CERO insiders and whales buy or sell their stock.
CERO Shareholders
What type of owners hold Cero Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Stuart M. Sloan | 1,791.97% | 21,600,442 | $40.61M | Insider |
| Brian G. Atwood | 1,667.42% | 20,099,097 | $37.79M | Insider |
| Yk Bioventures Opportunities GP I LLC | 1,078.91% | 13,005,169 | $24.45M | Insider |
| Christopher B. Ehrlich | 563.75% | 6,795,408 | $12.78M | Insider |
| Shami Patel | 92.94% | 1,120,254 | $2.11M | Insider |
| Phoenix Biotech Sponsor LLC | 82.96% | 1,000,000 | $1.88M | Insider |
| Kathleen Laporte | 80.62% | 971,825 | $1.83M | Insider |
| Daniel Corey | 22.23% | 267,912 | $503.67k | Insider |
| Parallel Advisors LLC | 18.25% | 220,000 | $413.60k | Institution |
| Robyn Rapaport | 4.15% | 50,000 | $94.00k | Insider |
CERO vs Biotech Stocks
Cero Therapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.